Add Formweb to your mobile device
HIGH ALERT: Please review policy carefully.
Search results for:
morphINE
morphINE
| Drug Name | Form | Strength | Woman's Hospital | Cancer Pavilion | Infusion Clinic |
|---|---|---|---|---|---|
| Morphine Sulfate (Dilution) | SOLUTION, INJECTABLE | 0.1 mg/mL | |||
| Duramorph PF | SOLUTION, INJECTABLE | 0.5 mg/mL preservative-free | |||
| Morphine Sulfate (Dilution) | SOLUTION, INJECTABLE | 0.5 mg/mL | |||
| Duramorph PF | SOLUTION, INJECTABLE | 1 mg/mL preservative-free (alternative due to shortage) | |||
| Morphine Sulfate | SOLUTION, INJECTABLE | 1 mg/mL | |||
| Morphine Sulfate | SOLUTION, INJECTABLE | 50 mg/mL | |||
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 1 mg/mL preservative-free | |||
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 4 mg/mL preservative-free | |||
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 5 mg/mL preservative-free | |||
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 10 mg/mL preservative-free | |||
| Morphine Sulfate (Compounding) | SOLUTION, ORAL | 0.4 mg/mL | |||
| Morphine Sulfate | SOLUTION, ORAL | 10 mg/5 mL | |||
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 15 mg/8 to 12 hr | |||
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 30 mg/8 to 12 hr | |||
| Morphine Sulfate | TABLET, ORAL | 15 mg |
High Alert Drug
: Policy
Last updated: Feb. 26, 2024
- Black Box Warning: Injection PreserveFree: 24-hour observation following epidural/intrathecal administration
- Black Box Warning: Controlled/Extended Release: Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome
- Look Alike/Sound Alike: MS Contin may be confused with OxyCONTIN
- Patient Education: Medication Card
- Protect from Light (Injectables) Storage, Dilution